PROCEPT BioRobotics Corp. (PRCT)
20.62
+0.35
(+1.73%)
USD |
NASDAQ |
Nov 06, 16:00
20.43
-0.19
(-0.92%)
After-Hours: 20:00
PROCEPT BioRobotics Research and Development Expense (Quarterly) : 20.01M for Sept. 30, 2026
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 20.01M |
| June 30, 2026 | 20.10M |
| March 31, 2026 | 21.46M |
| December 31, 2025 | 19.06M |
| September 30, 2025 | 18.19M |
| June 30, 2025 | 16.04M |
| March 31, 2025 | 16.40M |
| December 31, 2024 | 15.07M |
| September 30, 2024 | 15.32M |
| June 30, 2024 | 16.23M |
| March 31, 2024 | 11.90M |
| December 31, 2023 | 13.18M |
| September 30, 2023 | 10.55M |
| Date | Value |
|---|---|
| June 30, 2023 | 11.15M |
| March 31, 2023 | 9.449M |
| December 31, 2022 | 9.682M |
| September 30, 2022 | 6.141M |
| June 30, 2022 | 6.085M |
| March 31, 2022 | 5.011M |
| December 31, 2021 | 5.076M |
| September 30, 2021 | 4.919M |
| June 30, 2021 | 3.705M |
| March 31, 2021 | 4.522M |
| December 31, 2020 | 4.543M |
| September 30, 2020 | 3.893M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Insulet Corp. | 91.60M |
| Beta Bionics, Inc. | 11.98M |
| Abbott Laboratories | 920.00M |
| Baxter International, Inc. | 118.00M |
| Becton, Dickinson & Co. | 246.00M |